| Real-world patterns of endocrine therapy for metastatic hormone-receptor-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2−) breast cancer patients in the … E Swallow, J Zhang, D Thomason, RD Tan, A Kageleiry, J Signorovitch Current medical research and opinion 30 (8), 1537-1545, 2014 | 70 | 2014 |
| Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes L Shi, X Ye, M Lu, EQ Wu, H Sharma, D Thomason, VA Fonseca Diabetes care 36 (10), 3297-3304, 2013 | 33 | 2013 |
| Clinical outcomes and health-care resource use associated with reslizumab treatment in adults with severe eosinophilic asthma in real-world practice ME Wechsler, SP Peters, TD Hill, R Ariely, MR DePietro, MT Driessen, ... Chest 159 (5), 1734-1746, 2021 | 32 | 2021 |
| Comparative efficacy and incremental cost per responder of methotrexate versus apremilast for methotrexate-naïve patients with psoriasis AW Armstrong, KA Betts, M Sundaram, D Thomason, JE Signorovitch Journal of the American Academy of Dermatology 75 (4), 740-746, 2016 | 31 | 2016 |
| Economic burden of illness among commercially insured patients with systemic sclerosis with interstitial lung disease in the USA: a claims data analysis Z Zhou, Y Fan, D Thomason, W Tang, X Liu, ZY Zhou, D Macaulay, ... Advances in therapy 36, 1100-1113, 2019 | 26 | 2019 |
| Economic burden among commercially insured patients with systemic sclerosis in the United States Z Zhou, Y Fan, W Tang, X Liu, D Thomason, ZY Zhou, D Macaulay, ... The Journal of rheumatology 46 (8), 920-927, 2019 | 19 | 2019 |
| One-year and long-term molecular response to nilotinib and dasatinib for newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison JE Signorovitch, KA Betts, WM Reichmann, D Thomason, P Galebach, ... Current medical research and opinion 31 (2), 315-322, 2015 | 15 | 2015 |
| Association of antipsychotic treatment switching in patients with schizophrenia, bipolar, and major depressive disorders R Ayyagari, D Thomason, F Mu, M Philbin, B Carroll Journal of Medical Economics 23 (2), 204-212, 2020 | 12 | 2020 |
| Comparative efficacy of methotrexate versus apremilast for methotrexate-naive psoriasis patients: an indirect comparison AW Armstrong, K Betts, M Sundaram, D Thomason, J Signorovitch Journal of the American Academy of Dermatology 72 (5), AB229-AB229, 2015 | 4 | 2015 |
| Glycemic and cholesterol control versus single-goal control in US veterans with newly diagnosed type 2 diabetes: a retrospective observational study L Shi, X Ye, M Lu, EQ Wu, H Sharma, D Thomason, M Zhang, Y Wang, ... Diabetes Therapy 6, 339-355, 2015 | 3 | 2015 |
| 117 Impact of Antipsychotic Treatment Switching in Patients with Schizophrenia, Bipolar Disorder, and Major Depressive Disorder R Ayyagari, D Thomason, M Fan, M Philbin, B Carroll CNS spectrums 25 (2), 276-276, 2020 | 1 | 2020 |
| How is the severity of hidradenitis suppurativa measured in clinical practice? M Sundaram, P Lin, D Thomason, J Signorovitch JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 74 (5), AB6-AB6, 2016 | 1 | 2016 |
| Validation of the physician's global assessment of psoriasis of the hands and/or feet as a clinical endpoint O Goldblum, D Thomason, M Yang, M Sundaram JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 68 (4), AB218-AB218, 2013 | 1 | 2013 |
| Real-World Evidence of Improved Patient Outcomes with Reslizumab in Adults with Severe Eosinophilic Asthma: A Subgroup Analysis of Patients Receiving Reslizumab for More Than … M Wechsler, SP Peters, BE Chipps, T Hill, R Ariely, M DePietro, ... B101. NEW BIOLOGICAL TREATMENTS FOR ASTHMA, A4264-A4264, 2020 | | 2020 |
| Real-World Evidence of Improved Patient Outcomes with Reslizumab in Adults with Severe Eosinophilic Asthma (SEA): Subgroup Analyses of Patients Using Maintenance Oral … R Panettieri, M Wechsler, S Peters, B Chipps, T Hill, R Ariely, M Depietro, ... Journal of Allergy and Clinical Immunology 145 (2), AB26, 2020 | | 2020 |
| Real-world Evidence of Improved Patient Outcomes With Reslizumab in Non-exacerbating Patients With Severe Eosinophilic Asthma (SEA): A Subgroup Analysis S Peters, M Wechsler, B Chipps, T Hill, R Ariely, M Depietro, E Terasawa, ... Journal of Allergy and Clinical Immunology 145 (2), AB27, 2020 | | 2020 |
| Real-World Evidence of Reductions in Health Resource Utilization (HRU) and Improved Efficacy Outcomes Associated with Reslizumab Treatment in Adults with Severe Eosinophilic … M Wechsler, S Peters, B Chipps, T Hill, R Ariely, M Depietro, E Terasawa, ... Journal of Allergy and Clinical Immunology 145 (2), AB27, 2020 | | 2020 |
| P224 REAL-WORLD EVIDENCE OF IMPROVED PATIENT OUTCOMES WITH RESLIZUMAB IN ADULTS WITH SEVERE EOSINOPHILIC ASTHMA (SEA) M Wechsler, S Peters, B Chipps, T Hill, R Ariely, M DePietro, E Terasawa, ... Annals of Allergy, Asthma & Immunology 123 (5), S40, 2019 | | 2019 |
| Impact of Antipsychotic Treatment Switching in Patients With Schizophrenia, Bipolar Disorder, And Major Depressive Disorder (P2. 1-014) B Carroll, R Ayyagari, D Thomason, F Mu, M Philbin Neurology 92 (15 Supplement), 2019 | | 2019 |
| Impact of visceral metastases on treatment patterns for hormone-receptor-positive (HR plus)/human epidermal growth factor receptor-2-negative (HER2-) metastatic breast cancer (mBC) J Signorovitch, J Wang, RD Tan, D Thomason, A Kageleiry, E Swallow CANCER RESEARCH 75 (9), 2015 | | 2015 |
Andrew KageleiryPatchRxVerified email at patchrx.io
